A new strategy in designing and manufacturing novel pharmaceutical compounds is being developed in the University of Buffalo. A rhodium-based catalyst of 1 gram can produce 10,000 grams of a pharmaceutical product. This catalyst rhodium metal is ten times more expensive than gold. It is available only through chemical supply companies.
This new synthesis strategy generated compounds that react to diseases such as cancer, and inflammatory and microbial diseases.
The new method allows a molecule to be transformed from a simple structure to a more complex drug-like material. The resulting compounds are mirror-images, but are closely studied as opposite mirror-images have different biological effects which may be harmful.
Read the full article on this new technology.
